These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 378593)
21. The use of antilymphocyte globulin in renal allograft rejection. A controlled study. Birkeland SA Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853 [TBL] [Abstract][Full Text] [Related]
22. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients. Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659 [TBL] [Abstract][Full Text] [Related]
23. Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation? Mozes MF; Venkat KK; Kupin W; Dumler F; Gracida C; Uniewski M; Anaise D; Tang DH Transplant Proc; 1993 Feb; 25(1 Pt 1):575-6. PubMed ID: 8438420 [No Abstract] [Full Text] [Related]
24. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function. Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis in renal transplant recipients with and without donor-specific blood transfusion. Morad Z; Suleiman AB; Kong CT Transplant Proc; 1989 Feb; 21(1 Pt 2):1825-6. PubMed ID: 2652593 [No Abstract] [Full Text] [Related]
26. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants. Sansom JR; Barnes AD; Hall CL Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851 [TBL] [Abstract][Full Text] [Related]
27. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Wieneke H; Otte B; Lang D; Heidenreich S Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953 [TBL] [Abstract][Full Text] [Related]
28. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation. Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505 [No Abstract] [Full Text] [Related]
29. Heart transplantation in females. Esmore D; Keogh A; Spratt P; Jones B; Chang V J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761 [TBL] [Abstract][Full Text] [Related]
30. Kidney transplantation in pediatric population. Mota C; Henriques C; Sarmento M; Pereira E; Xavier E; Pereira M Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872 [No Abstract] [Full Text] [Related]
31. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol. Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564 [No Abstract] [Full Text] [Related]
32. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine. Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898 [No Abstract] [Full Text] [Related]
33. Late acute rejection in renal transplant recipients: response to steroid treatment. Prieto C; Pulido F; Rodríguez-Paternina E; Algranati C; Bello I; Farias J; G-Millet V Transplant Proc; 1992 Feb; 24(1):35-6. PubMed ID: 1539312 [No Abstract] [Full Text] [Related]
34. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression. Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566 [No Abstract] [Full Text] [Related]
35. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts. Menkis AH; Powell AM; Novick RJ; McKenzie FN; Kostuk WJ; Pflugfelder PW; Brown JE; Rochon J; Chow LH; Stiller C J Heart Lung Transplant; 1992; 11(3 Pt 1):569-76. PubMed ID: 1610866 [TBL] [Abstract][Full Text] [Related]